Purdue Pharma L.P.

Track this case

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

July 01, 2025
Top Personal Injury, Med Mal News: 2025 Midyear Report

A U.S. Supreme Court ruling over whether personal injury claims can be brought under a RICO statute and a $7.4 billion settlement reached with the Sackler family and Purdue Pharma are among Law360's top personal injury and medical malpractice cases from the first six months of 2025.
June 23, 2025
23andMe Sale Nears Ruling, Tariff Policies Drive Bankruptcy

A Missouri bankruptcy judge said he will soon rule on the proposed $305 million sale of 23andMe to a nonprofit led by its co-founder. Meanwhile, shifting tariff policies under President Donald Trump have been blamed for recent bankruptcies, and experts at a conference in New York discussed the future of Chapter 11 and how a second Trump term could shape bankruptcy law.
June 20, 2025
2nd Purdue Plan Heading For Creditor Vote, Nov. Hearing

A New York bankruptcy judge Friday set OxyContin maker Purdue Pharma's second try at a bankruptcy plan on course for a November confirmation hearing, clearing the plan disclosure statement to be sent out for a creditor vote.
June 18, 2025
Purdue Pharma Seeks Vote On New $8B Ch. 11 Plan

Close to a year after the U.S. Supreme Court shot down an earlier version of its Chapter 11 plan, OxyContin maker Purdue Pharma was before a New York bankruptcy judge Wednesday to ask for permission to send its revised plan out for a creditor vote.
June 16, 2025
All 50 States Agree To Purdue Pharma's $7.4B Settlement

Attorneys general from 55 U.S. states and territories on Monday backed Purdue Pharma's $7.4 billion deal to settle opioid injury claims against the company and the Sackler family, almost a year after the U.S. Supreme Court threw out Purdue's previous plan to end litigation over its role in the opioid epidemic.
June 13, 2025
What's Happening In Bankruptcy Court This Coming Week

Vodka company Stoli Group and pharmaceutical giant Purdue are both headed to court to make the case for their bankruptcy plan disclosure statements, New Hampshire power plant operator Burgess BioPower will try to get its Chapter 11 plan confirmed, and trucking company Yellow Corp. is facing a bid to send it to liquidation.
June 12, 2025
McKinsey Says Purdue Ch. 11 Plan Endangers Sackler Claims

McKinsey & Co. has asked a New York bankruptcy judge to reject the disclosure statement for Purdue Pharma's Chapter 11 plan, saying there is ambiguity on how the plan will deal with the consulting firm's possible claims against former owners in the Sackler family.
June 06, 2025
Purdue Seeks To Stretch Ch. 11 Injunction To November

Purdue Pharma has asked a New York bankruptcy judge to extend a litigation injunction in its Chapter 11 until late November or after it secures confirmation of its bankruptcy plan, whichever is earlier, saying the stay is protecting dozens of settlements.
May 22, 2025
Purdue Eyes Fall Confirmation For New Chapter 11 Plan

Attorneys for Purdue Pharma told a New York bankruptcy judge Thursday that the company aims to send its Chapter 11 plan to a vote over the summer with a fall confirmation hearing to conclude the nearly 6-year-old case.
April 14, 2025
Debt Deals On The Rise, Purdue Can Begin Claims Processing

A Texas district court, not a bankruptcy court, will oversee the U.S. trustee's efforts to claw back millions in legal fees paid to Jackson Walker over an undisclosed relationship between an attorney and bankruptcy judge; out-of-court debt deals eclipsed Chapter 11s by a 4-to-1 ratio last year; and drug manufacturer Purdue Pharma can begin processing claims ahead of a Chapter 11 confirmation hearing. This is the week in bankruptcy.

← Previous
1
2
3
4
5
6
7
8
9
…
Next →